These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38072378)

  • 21. Epidemiology of Clinically Relevant Bleeding in Critically Ill Adolescents.
    Pinto MG; Shabanova V; Li S; Trakas E; Miksa M; Gertz S; Polikoff LA; Tala JA; Faustino EVS;
    Pediatr Crit Care Med; 2019 Oct; 20(10):907-913. PubMed ID: 31261231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
    Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
    J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient selection for thromboprophylaxis in medical inpatients.
    Bozzato S; Squizzato A; Donadini MP; Guasti L; Dentali F; Ageno W
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1639-47. PubMed ID: 24215194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study.
    Chopard P; Spirk D; Beer HJ; Peter J; Brunner B; Bounameaux H; Dörfller-Melly J
    Swiss Med Wkly; 2009 Oct; 139(43-44):630-5. PubMed ID: 19950025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
    Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
    Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.
    Cohoon KP; De Sanctis Y; Haskell L; McBane RD; Spiro TE
    J Thromb Haemost; 2018 Jul; 16(7):1278-1287. PubMed ID: 29753308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
    Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
    Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
    Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
    Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study.
    Silvestri F; Pasca S; Labombarda A; Barbi A; Desideri M; Guidi P; Rogato A; Zaramella M; Bergamo M; Ageno W; Barillari G
    Minerva Med; 2014 Jun; 105(3):221-8. PubMed ID: 24988087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, Predictors, and Outcomes of Hospital-Acquired Anemia.
    Makam AN; Nguyen OK; Clark C; Halm EA
    J Hosp Med; 2017 May; 12(5):317-322. PubMed ID: 28459899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we under-treating our patients?
    Roth-Yelinek B
    Eur J Intern Med; 2012 Apr; 23(3):236-9. PubMed ID: 22385880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of bleeding in patients being considered for venous thromboembolism prophylaxis.
    Sahoo S; Hayssen H; Englum B; Mayorga-Carlin M; Siddiqui T; Nguyen P; Kankaria A; Yesha Y; Sorkin JD; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2023 Nov; 11(6):1182-1191.e13. PubMed ID: 37499868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.
    Le P; Martinez KA; Pappas MA; Rothberg MB
    J Thromb Haemost; 2017 Jun; 15(6):1132-1141. PubMed ID: 28371250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.
    Choffat D; Farhoumand PD; Jaccard E; de la Harpe R; Kraege V; Benmachiche M; Gerber C; Leuzinger S; Podmore C; Truong MK; Dumans-Louis C; Marti C; Reny JL; Aujesky D; Rakovic D; Limacher A; Rossel JB; Baumgartner C; Méan M
    PLoS One; 2022; 17(5):e0268833. PubMed ID: 35609087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.
    Senay A; Trottier M; Delisle J; Banica A; Benoit B; Laflamme GY; Malo M; Nguyen H; Ranger P; Fernandes JC
    Vasc Health Risk Manag; 2018; 14():81-89. PubMed ID: 29780248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of falls and bleeding in elderly patients with acute venous thromboembolism.
    Kämpfen P; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Cornuz J; Banyai M; Egloff M; Aschwanden M; Bounameaux H; Rodondi N; Aujesky D
    J Intern Med; 2014 Oct; 276(4):378-86. PubMed ID: 24645727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
    Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
    J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.